|
|
|
|
|
|
|
|
|
|
|
|
|
23.09.25 - 14:00
|
Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors (The Newswire)
|
|
|
TORONTO and BOSTON - September 22, 2025 - TheNewswire — Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced the appointment of John L. Brooks III as Chair of the Company's Board of Directors.
“We are honored to have John lead our Board at this exciting time for Sernova,” said Jonathan Rigby, CEO of Sernova. “His deep experience in T1D, venture capital and building early-stage companies will be invaluable as we advance our Cell Pouch Bio-hybrid Organ as a functional cure for T1D into the final cohort of our ongoing phase 1 / 2 clinical trial.”
John L. Brooks III currently serves as Managing Director at Healthcare Capital LLC, where he advises early-stage life science companies and also as the CEO of Diamune that is developing innovative IgG Fc-Fusion insulin analogs. During his career, Mr. Brooks ...
|
|
|
08.09.25 - 16:01
|
Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference (The Newswire)
|
|
|
London, Ontario – TheNewswire - September 8, 2025 - Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced it will be participating in the upcoming H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025.
Jonathan Rigby, Sernova's President and CEO, will provide a company overview in a virtual presentation and will be participating in virtual one-on-one investor meetings. Please contact your representative at H.C. Wainwright to schedule a meeting with the management team during the conference.
ABOUT SERNOVA BIOTHERAPEUTICS
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. ...
|
|
|
|
|
02.06.25 - 22:18
|
Sernova Appoints Jonathan Rigby as Interim Chair (GlobeNewswire EN)
|
|
|
LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced the appointment of Sernova's Chief Executive Officer Jonathan Rigby as Interim Chair of the board of directors. Mr. Rigby will assume the Chair role, effective immediately, until a new independent director is appointed to serve as the next Chair of the Board....
|
|
|
|
|
26.05.25 - 06:03
|
Chair of Sernova Biotherapeutics Resigns (GlobeNewswire EN)
|
|
|
LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced the resignation of its Chair....
|
|
|
15.04.25 - 22:09
|
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med (GlobeNewswire EN)
|
|
|
LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company's Cell Pouch Bio-hybrid Organ in clinical development as a functional cure for type 1 diabetes (T1D) will be highlighted in a panel discussion titled Diabetes – Cell and Tissue Therapy Approaches to Provide Durable Therapeutic Solutions at the 2025 Cell & Gene Meeting on the Med conference in Rome, Italy on Wednesday, April 16, 2025....
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
